During DCAT Week, we had the pleasure of engaging in a conversation with Paolo Paissoni, Director of Innovation & Business Development at PROCOS (CBC Group) regarding the recent investment in HPAPI expansion.
TWENTYFOURSEVENBIOPHARMA
During DCAT Week, we had the pleasure of engaging in a conversation with Paolo Paissoni, Director of Innovation & Business Development at PROCOS (CBC Group) regarding the recent investment in HPAPI expansion.